Physician profile
Patrick Stephen Harris
NPI 1710410436
$1,510.96
in general payments reported to CMS, 2019-2025
17 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $852 · 2024: $272 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $832.20 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $179.58 | 2023-2025 | Xifaxan, Plenvu, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $96.26 | 2023-2025 | Entyvio |
| Ardelyx, INC. | $93.33 | 2023-2025 | Ibsrela |
| Boston Scientific Corporation | $61.51 | 2025 | Watchman Flx, Resolution 360 Ultra Clip |
| Genzyme Corporation | $32.16 | 2023-2025 | |
| Qol Medical, LLC | $31.09 | 2023 | Sucraid |
| Gilead Sciences, INC. | $26.58 | 2023 | Epclusa |
| Merck Sharp & Dohme LLC | $23.49 | 2023 | Dificid |
| Lilly USA, LLC | $20.77 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $19.39 | 2025 | Iqirvo |
| Nestle Healthcare Nutrition INC. | $19.09 | 2023 | |
| Celgene Corporation | $19.01 | 2024 | Zeposia |
| Celltrion USA INC. | $16.87 | 2025 | Vegzelma |
| Janssen Biotech, INC. | $15.43 | 2023 | Stelara |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $12.77 | 2023 | Ocaliva |
| Phathom Pharmaceuticals, INC. | $11.43 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.